Originally published at: Evaluating GenMol as a Generalist Foundation Model for Molecular Generation | NVIDIA Technical Blog
Traditional computational drug discovery relies almost exclusively on highly task-specific computational models for hit identification and lead optimization. Adapting these specialized models to new tasks requires substantial time, computational power, and expertise—challenges that grow when researchers simultaneously work across multiple targets or properties. While specialized models remain widely used, the rise of generalist models has…